...
机译:Meta‐analysis of head‐to‐head clinical trials comparing incretin‐based glucose‐lowering medications and basal insulin: An update including recently developed glucagon‐like peptide‐1 (GLP‐1) receptor agonists and the glucose‐dependent insulinotropic polypeptide/GLP‐1 receptor co‐agonist tirzepatide
Diabetes, Endocrinology and Metabolism Section, Medical Department I,Katholisches Klinikum Bochum;
body weight; fasting plasma glucose; GIP/GLP‐1 receptor co‐agonists; basal insulin; GLP‐1 receptor agonists; glycaemic control; HbA1c; type 2 diabetes;